Beijing Health Guard Biotechnology (BJSE:833575) Total Liabilities : ¥785.65 Mil (As of Jun. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Beijing Health Guard Biotechnology Total Liabilities?

Beijing Health Guard Biotechnology's Total Liabilities for the quarter that ended in Jun. 2024 was ¥785.65 Mil.

Beijing Health Guard Biotechnology's quarterly Total Liabilities increased from Dec. 2023 (¥547.37 Mil) to Mar. 2024 (¥686.00 Mil) and increased from Mar. 2024 (¥686.00 Mil) to Jun. 2024 (¥785.65 Mil).

Beijing Health Guard Biotechnology's annual Total Liabilities increased from Dec. 2021 (¥278.59 Mil) to Dec. 2022 (¥449.15 Mil) and increased from Dec. 2022 (¥449.15 Mil) to Dec. 2023 (¥547.37 Mil).

Beijing Health Guard Biotechnology Total Liabilities Historical Data

The historical data trend for Beijing Health Guard Biotechnology's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Health Guard Biotechnology Total Liabilities Chart

Beijing Health Guard Biotechnology Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

72.14

168.93

278.59

449.15

547.37

Beijing Health Guard Biotechnology Quarterly Data
	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Total Liabilities	Get a 7-Day Free Trial															373.28	455.78	547.37	686.00	785.65

Beijing Health Guard Biotechnology Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Beijing Health Guard Biotechnology's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	500.317	+	(36.547	+	10.509
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	547.37

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	1454.292	-	906.919
	=	547.37

Beijing Health Guard Biotechnology's Total Liabilities for the quarter that ended in Jun. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	707.285	+	(62.378	+	15.988
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	785.65

Total Liabilities	=	Total Assets (Q: Jun. 2024 )	-	Total Equity (Q: Jun. 2024 )
	=	1508.353	-	722.702
	=	785.65

Beijing Health Guard Biotechnology Total Liabilities Related Terms

Thank you for viewing the detailed overview of Beijing Health Guard Biotechnology's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Beijing Health Guard Biotechnology Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Beijing Health Guard Biotechnology Inc (BJSE:833575) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 7 Rongchang East Street, Beijing Economic and Technological Development Zone, Room 201 and 202, Building A2, Beijing, CHN, 100176

Website

Beijing Health Guard Biotechnology Inc engages in the research, development, and industrialization of recombinant protein vaccines. It mainly develops HPV vaccines in China and also advances multiple innovative candidate vaccines for other infectious diseases. Its core pipeline product includes a trivalent and a nonavalent HPV vaccine.

Beijing Health Guard Biotechnology Headlines

No Headlines